rdf:type |
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0019764,
umls-concept:C0022646,
umls-concept:C0063695,
umls-concept:C0185117,
umls-concept:C0277785,
umls-concept:C0450127,
umls-concept:C0456387,
umls-concept:C0552639,
umls-concept:C1510483,
umls-concept:C1883727,
umls-concept:C2911684
|
pubmed:issue |
1
|
pubmed:dateCreated |
1996-7-23
|
pubmed:abstractText |
Percutaneous biopsy is the method of choice for differential diagnosis of renal allograft dysfunction, although it is not risk-free. The use of less aggressive methods for diagnosis should limit the need for percutaneous biopsy to some specific situations.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0931-0509
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
148-52
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8649624-Acute Disease,
pubmed-meshheading:8649624-Biopsy, Needle,
pubmed-meshheading:8649624-Diagnosis, Differential,
pubmed-meshheading:8649624-Graft Rejection,
pubmed-meshheading:8649624-HLA-DR Antigens,
pubmed-meshheading:8649624-Humans,
pubmed-meshheading:8649624-Immunohistochemistry,
pubmed-meshheading:8649624-Intercellular Adhesion Molecule-1,
pubmed-meshheading:8649624-Kidney Transplantation,
pubmed-meshheading:8649624-Kidney Tubules
|
pubmed:year |
1996
|
pubmed:articleTitle |
HLA-DR class II and ICAM-1 expression on tubular cells taken by fine-needle aspiration biopsy in renal allograft dysfunction.
|
pubmed:affiliation |
Nephrology Service, Hospital Universitario de Canarias, Tenerife, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|